GNRH1 and osteoporosis: The decision regarding whether this is a suitable option for an individual patient should include an assessment of contraindications such as known osteoporosis or severe hepatic impairment and consideration for conditions that might influence treatment efficacy such as a history of nonresponse to GnRH agonists or antagonists.